MEIP - MEI Pharma GAAP EPS of -$0.07 beats by $0.11 revenue of $9.7M beats by $6.26M May, 23 2022 04:40 PM MEI Pharma Inc. MEI Pharma press release (NASDAQ:MEIP): Q3 GAAP EPS of -$0.07 beats by $0.11. Revenue of $9.7M (+19.8% Y/Y) beats by $6.26M. For further details see: MEI Pharma GAAP EPS of -$0.07 beats by $0.11, revenue of $9.7M beats by $6.26M